InflaRx Announces Positive Initial Data from Phase IIa Clinical Trial

On February 26, InflaRx, N.V. (IFRX) announced positive initial data from the first 5 patients enrolled in its Phase IIa open label clinical trial for IFX-1. Two out of the five patients achieved complete remission of Pyoderma Gangraenosum (PG), a rare and debilitating autoinflammatory skin disease. Although the exact prevalence of PG is unknown, current […]

Read more...

Brighthouse Financial Expands Existing Share Repurchase Program

On February 10, Brighthouse Financial Inc., (BHF) reported that the company’s Board of Directors authorized a $500 million share repurchase program.  This authorization is in addition to the $600 million in share repurchase authorization outstanding from August 2018 and May 2019.  Brighthouse Financial has already repurchased approximately $570 million in common stock.   Sonal alerted […]

Read more...

January 2020 Scorecard

The January 2020 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...